Clinical Trials
60 trialsSTARTRK-2
Hoffmann-La Roche
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
Roswell Park Cancer Institute
TUXEDO-4
MedSIR
TUXEDO-3
MedSIR
Brain Radiotherapy Combined With Dalpiciclib and Endocrine Therapy in HR-Positive/HER2-Negative Advanced Breast Cancer With Brain Metastases
Nanfang Hospital, Southern Medical University
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
National Cancer Institute (NCI)
Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
Brigham and Women's Hospital
BERLIN
Yale University
Study Assessing QBS72S For Treating Brain Metastases
Stanford University
Trial of Neratinib Plus Capecitabine in Subjects With HER2-Negative Metastatic Breast Cancer With Brain Metastases and Abnormally Active HER2 Signaling
University of Rochester
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
Beijing Biostar Pharmaceuticals Co., Ltd.
DEBBRAH
MedSIR
RTA 744 in Breast Cancer Patients With Progression of Previously Irradiated Brain Metastases
Biogen
BALISTA
Fudan University
Sacituzumab Govitecan Combined With Head Radiotherapy for Her2-negative Breast Cancer Brain Metastases
Guangzhou Medical University
Phase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer
Stanford University
Pyrotinib Combined With Capecitabine and Bevacizumab for Patients With HER2 Positive Breast Cancer and Brain Metastases
Tongji Hospital
A Phase II Study of T-DXd Plus SRT in HER2-positive Breast Cancer Brain Metastases
Fudan University
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
National Cancer Institute (NCI)
HER2CLIMB
Seagen Inc.
ALpha-T
Hoffmann-La Roche
Combination Liposomal Irinotecan and Pembrolizumab For Triple-Negative Breast Cancer (TNBC) With Brain Metastases (BM)
Washington University School of Medicine
Neoadjuvant Immunotherapy in Brain Metastases
Duke University
ARX788 in HER2-positive Breast Cancer Patients With Brain Metastases
Fudan University
Palbociclib, Trastuzumab,Pyrotinib and Fulvestrant Treatment in Patients With Brain Metastasis From ER/PR Positive, HER-2 Positive Breast Cancer: A Multi-center, Prospective Study in China
Sun Yat-sen University
NeraBrain
Jules Bordet Institute
STAR Cape+BKM120 MBC With Brain Met
US Oncology Research
Cabozantinib +/- Trastuzumab In Breast Cancer Patients w/ Brain Metastases
Dana-Farber Cancer Institute
A-Plus
National Taiwan University Hospital
A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain
Eli Lilly and Company
DM-CHOC-PEN
DEKK-TEC, Inc.
Treatment of Brain Metastases From Breast Cancer With Eribulin Mesylate
Case Comprehensive Cancer Center
ERIBRAIN
Institut Paoli-Calmettes
ANG1005 in Breast Cancer Patients With Recurrent Brain Metastases
Angiochem Inc
Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer
Novartis
OPTIMAL
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
FSRT in Breast Cancer Patients With Brain Metastases
Fudan University
Pyrotinib
ChineseAMS
A Study Of Everolimus, Trastuzumab And Vinorelbine In HER2-Positive Breast Cancer Brain Metastases
UNC Lineberger Comprehensive Cancer Center
TPI 287 in Breast Cancer Metastatic to the Brain
M.D. Anderson Cancer Center
Irinotecan and Temozolomide in Treating Patients With Breast Cancer Who Have Received Previous Treatment for Brain Metastases
University of California, San Francisco
CaBaMet
AIO-Studien-gGmbH
Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast Cancer
University of Washington
STOP
Merck Sharp & Dohme LLC
GRABM-B
Angiochem Inc
A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis
Sanofi
Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases
Memorial Sloan Kettering Cancer Center
Brain Metastases In ErbB2-Positive Breast Cancer
GlaxoSmithKline
Lapatinib and WBRT for Patients With Brain Metastases From Lung or Breast Tumors
Hellenic Cooperative Oncology Group
Brain Mets - Capecitabine Plus Sunitinib and WBRT
Baylor Breast Care Center